Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin-Feng Feng

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|March 8, 2013
One potential oncolytic adenovirus expressing Lipocalin-2 for colorectal cancer therapyBin Xu, Wen-Yan Zheng, Jin-Feng Feng, et al.
Nature Communications|March 29, 2024
Catalytic polymer self-cleavage for CO<sub>2</sub> generation before combustion empowers materials with fire safetyWei Luo, Ming-Jun Chen, Ting Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 10, 2020
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinomaFei Teng, Ju-Xiang Zhang, Qi-Meng Chang, et al.
Annals of Hepatology|February 20, 2025
MCM3 promotes hepatocellular carcinoma progression via Epithelial-mesenchymal Transition through AKT/Twist signaling pathwayWei-Guo Tang, Jin-Feng Feng, Xian Li, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Biotherapy & Radiopharmaceuticals|March 8, 2013
One potential oncolytic adenovirus expressing Lipocalin-2 for colorectal cancer therapyBin Xu, Wen-Yan Zheng, Jin-Feng Feng, et al.
Nature Communications|March 29, 2024
Catalytic polymer self-cleavage for CO<sub>2</sub> generation before combustion empowers materials with fire safetyWei Luo, Ming-Jun Chen, Ting Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 10, 2020
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinomaFei Teng, Ju-Xiang Zhang, Qi-Meng Chang, et al.
Annals of Hepatology|February 20, 2025
MCM3 promotes hepatocellular carcinoma progression via Epithelial-mesenchymal Transition through AKT/Twist signaling pathwayWei-Guo Tang, Jin-Feng Feng, Xian Li, et al.
Pageof 1